These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11435429)

  • 1. Bisphosphonates are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase.
    Montalvetti A; Bailey BN; Martin MB; Severin GW; Oldfield E; Docampo R
    J Biol Chem; 2001 Sep; 276(36):33930-7. PubMed ID: 11435429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Farnesyl pyrophosphate synthase is an essential enzyme in Trypanosoma brucei. In vitro RNA interference and in vivo inhibition studies.
    Montalvetti A; Fernandez A; Sanders JM; Ghosh S; Van Brussel E; Oldfield E; Docampo R
    J Biol Chem; 2003 May; 278(19):17075-83. PubMed ID: 12618430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the farnesyl pyrophosphate synthase of Trypanosoma cruzi by homology modeling and molecular dynamics.
    Sigman L; Sánchez VM; Turjanski AG
    J Mol Graph Model; 2006 Nov; 25(3):345-52. PubMed ID: 16540358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure and mechanism of the farnesyl diphosphate synthase from Trypanosoma cruzi: implications for drug design.
    Gabelli SB; McLellan JS; Montalvetti A; Oldfield E; Docampo R; Amzel LM
    Proteins; 2006 Jan; 62(1):80-8. PubMed ID: 16288456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisphosphonates derived from fatty acids are potent inhibitors of Trypanosoma cruzi farnesyl pyrophosphate synthase.
    Szajnman SH; Montalvetti A; Wang Y; Docampo R; Rodriguez JB
    Bioorg Med Chem Lett; 2003 Oct; 13(19):3231-5. PubMed ID: 12951099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective in vitro effects of the farnesyl pyrophosphate synthase inhibitor risedronate on Trypanosoma cruzi.
    Garzoni LR; Caldera A; Meirelles Mde N; de Castro SL; Docampo R; Meints GA; Oldfield E; Urbina JA
    Int J Antimicrob Agents; 2004 Mar; 23(3):273-85. PubMed ID: 15164969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrogen-containing bisphosphonates as carbocation transition state analogs for isoprenoid biosynthesis.
    Martin MB; Arnold W; Heath HT; Urbina JA; Oldfield E
    Biochem Biophys Res Commun; 1999 Oct; 263(3):754-8. PubMed ID: 10512752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of nitrogen-containing bisphosphonates (N-BPs) to the Trypanosoma cruzi farnesyl diphosphate synthase homodimer.
    Huang CH; Gabelli SB; Oldfield E; Amzel LM
    Proteins; 2010 Mar; 78(4):888-99. PubMed ID: 19876942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs.
    Kavanagh KL; Guo K; Dunford JE; Wu X; Knapp S; Ebetino FH; Rogers MJ; Russell RG; Oppermann U
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7829-34. PubMed ID: 16684881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.
    Dunford JE; Thompson K; Coxon FP; Luckman SP; Hahn FM; Poulter CD; Ebetino FH; Rogers MJ
    J Pharmacol Exp Ther; 2001 Feb; 296(2):235-42. PubMed ID: 11160603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystallization and preliminary neutron diffraction experiment of human farnesyl pyrophosphate synthase complexed with risedronate.
    Yokoyama T; Ostermann A; Mizuguchi M; Niimura N; Schrader TE; Tanaka I
    Acta Crystallogr F Struct Biol Commun; 2014 Apr; 70(Pt 4):470-2. PubMed ID: 24699741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The intracellular target for the antiresorptive aminobisphosphonate drugs in Dictyostelium discoideum is the enzyme farnesyl diphosphate synthase.
    Grove JE; Brown RJ; Watts DJ
    J Bone Miner Res; 2000 May; 15(5):971-81. PubMed ID: 10804029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein geranylgeranyltransferase-I of Trypanosoma cruzi.
    Yokoyama K; Gillespie JR; Van Voorhis WC; Buckner FS; Gelb MH
    Mol Biochem Parasitol; 2008 Jan; 157(1):32-43. PubMed ID: 17996962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The farnesyl-diphosphate/geranylgeranyl-diphosphate synthase of Toxoplasma gondii is a bifunctional enzyme and a molecular target of bisphosphonates.
    Ling Y; Li ZH; Miranda K; Oldfield E; Moreno SN
    J Biol Chem; 2007 Oct; 282(42):30804-16. PubMed ID: 17724033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for bisphosphonate-mediated inhibition of isoprenoid biosynthesis.
    Hosfield DJ; Zhang Y; Dougan DR; Broun A; Tari LW; Swanson RV; Finn J
    J Biol Chem; 2004 Mar; 279(10):8526-9. PubMed ID: 14672944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and expression of a farnesyl diphosphate synthase in Centella asiatica (L.) Urban.
    Kim OT; Ahn JC; Hwang SJ; Hwang B
    Mol Cells; 2005 Apr; 19(2):294-9. PubMed ID: 15879717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase.
    Bergstrom JD; Bostedor RG; Masarachia PJ; Reszka AA; Rodan G
    Arch Biochem Biophys; 2000 Jan; 373(1):231-41. PubMed ID: 10620343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structures of undecaprenyl pyrophosphate synthase in complex with magnesium, isopentenyl pyrophosphate, and farnesyl thiopyrophosphate: roles of the metal ion and conserved residues in catalysis.
    Guo RT; Ko TP; Chen AP; Kuo CJ; Wang AH; Liang PH
    J Biol Chem; 2005 May; 280(21):20762-74. PubMed ID: 15788389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights into molecular recognition of 1,1-bisphosphonic acids by farnesyl diphosphate synthase.
    Ferrer-Casal M; Li C; Galizzi M; Stortz CA; Szajnman SH; Docampo R; Moreno SN; Rodriguez JB
    Bioorg Med Chem; 2014 Jan; 22(1):398-405. PubMed ID: 24300918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological evaluation of new 2-alkylaminoethyl-1,1-bisphosphonic acids against Trypanosoma cruzi and Toxoplasma gondii targeting farnesyl diphosphate synthase.
    Rosso VS; Szajnman SH; Malayil L; Galizzi M; Moreno SN; Docampo R; Rodriguez JB
    Bioorg Med Chem; 2011 Apr; 19(7):2211-7. PubMed ID: 21419634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.